Page last updated: 2024-10-24

candesartan and Extravasation of Contrast Media

candesartan has been researched along with Extravasation of Contrast Media in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Treatment with candesartan increased EB extravasation in the kidney in normovolaemic controls."1.33Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats. ( Binkowski, K; Dendorfer, A; Eichler, W; Klotz, KF; Puchakayala, MR; Schumacher, J, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schumacher, J1
Puchakayala, MR1
Binkowski, K1
Eichler, W1
Dendorfer, A1
Klotz, KF1

Other Studies

1 other study available for candesartan and Extravasation of Contrast Media

ArticleYear
Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats.
    British journal of anaesthesia, 2006, Volume: 96, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimid

2006